Search for: "Abbott Laboratories v. Kappos"
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
19 Oct 2011, 11:27 am
In 2005, the Court granted certiorari on related issues in Laboratory Corp. of America v. [read post]
16 Jun 2010, 3:02 pm
Kappos (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
14 Jan 2013, 4:30 am
Kappos) Last week the Federal Circuit heard oral argument (here) in Abbott Laboratories v. [read post]
14 Jul 2010, 6:47 pm
Kappos (Patent Docs) US: Review and correction of the patent term adjustment calculation: Nippon Shinyaku Co., Ltd. v. [read post]
13 May 2010, 4:58 pm
Barr Laboratories, Inc. [read post]
6 Jul 2010, 6:03 pm
Siemens (EPLAW) India: Novartis & Bayer appeals to be heard by the Supreme Court in the next 30 days (Spicy IP) US: House passes patent settlement legislation as part of the War Funding Bill (FDA Law Blog) US: Bilski v Kappos: What effects on biotechnology patents? [read post]
7 Jul 2010, 5:14 am
Siemens (EPLAW) India: Novartis & Bayer appeals to be heard by the Supreme Court in the next 30 days (Spicy IP) US: House passes patent settlement legislation as part of the War Funding Bill (FDA Law Blog) US: Bilski v Kappos: What effects on biotechnology patents? [read post]
9 Sep 2009, 7:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: CAFC debates whether claim term ‘animal’ includes humans: Martek Biosciences Corp v Nutrinova, Inc (Gray on Claims) (Patently-O) (Patently-O) (IP Watchdog) General USPTO-Pfizer workshop on IP & innovation in Mumbai (Intellectual Property Watch) Australia: Full Federal Court unanimously… [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc.; Abbott Laboratories et al. v. [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
18 Mar 2010, 2:30 am
Abbott Laboratories (Patent Docs) Flomax (Tamsulosin) – US: The last shall be first... [read post]
15 Jun 2011, 4:56 am
(Patent Docs) Zemplar (Paricalcitol) – US: Patent infringement complaint filed in response to Para IV certification: Abbott Laboratories et al. v. [read post]
21 Mar 2013, 7:55 pm
AIA Cited by CAFC as Remedying Known Patent Reexamination Deficiency As predicted based upon the earlier oral argument, the Federal Circuit closed the door on the potential for discovery in inter partes patent reexamination in Abbott Laboratories v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Seasonique (Levonorgestrel, ethinyl estradiol) – US: Teva files patent infringement suit against Lupin in response to Para IV challenge (Patent Docs) Simcor (Simvastatin, niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
19 May 2010, 6:15 am
(Patent Docs) US: CAFC affirms claim construction and corresponding summary judgment of non-infringement: Scantibodies Laboratory, Inc. v. [read post]
27 May 2010, 3:20 am
(Spicy IP) Trilipix (Fenofibrate) – US: Patent infringement complaint following Paragraph IV challenge: Abbott Laboratories et al. v. [read post]
29 Dec 2010, 2:57 am
Highlights this week included: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
8 Mar 2011, 1:23 pm
Cir. 2009) (en banc in part) Abbott Laboratories v. [read post]
7 Apr 2010, 4:30 am
: The Medicines Company v Kappos (Peter Zura's 271 Patent Blog) Cancidas (Caspofungin) – US: District Court New Jersey: Merck & Co files patent infringement complaint following Para IV challenge by Sandoz (Patent Docs) Clarinex (Desloratadine) - US: Mass forfeiture of 180-day exclusivity! [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
